This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The All India Pharmaceutical Associations Consortium (AIPAC) launched its first programme for Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector on 12 December 2024. The event took place at the Prestige Institute of Management & Research, Indore, and was inaugurated by Dr Rajeev Singh Raghuvanshi, the Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO).
REMODULIN (treprostinil) United therap Patent: 10,076,505 Expiration: Dec 16, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
Glenmark Pharmaceuticals, USA, has announced the launch of its Lacosamide Oral Solution, 10 mg/mL. The product is bioequivalent and therapeutically equivalent to Vimpat Oral Solution, 10 mg/mL, the reference listed drug by UCB, Inc. According to IQVIA sales data for the 12-month period ending October 2024, the market for Vimpat Oral Solution, 10 mg/mL, recorded annual sales of approximately $57 million.
In this posta list of peculiar journal articles are highlighted, which may serve as conversationstarters from the medical literature. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Social events like holiday parties or kids birthday parties can be unpredictable. Sometimes you know everyone and it is a lot of fun. Sometimes you do not know many people and you are stuck trying to make conversation with new acquaintances.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Hypertension is one of the most common disease states that can lead to an increase in cardiovascular risk and other complications. Because of the risks of elevated blood pressure, we are often forced to use pharmacotherapy to reduce those risks. When a medication is started (or increased), we encounter risk in the form of adverse […] The post Hypertension Prescribing Cascade – 3 Common Examples appeared first on Med Ed 101.
Kiran Mazumdar-Shaw, Chairperson of Biocon Group, was conferred the Jamsetji Tata Award by the Indian Society for Quality (ISQ) on December 14, 2024, in Bengaluru, Karnataka. The award recognises her pioneering efforts in the biosciences sector and her commitment to quality, which has led Biocon to achieve a leading position in the global biopharmaceutical industry.
Rusan Pharma, a global pharm company specialising in addiction treatment and pain management, has reached two significant milestones for its dedicated high-speed transdermal patch and oral film manufacturing facility at the Kandla Special Economic Zone (SEZ)-UNIT-II in Gujarat, India. The facility has recently received Good Manufacturing Practice (GMP) approval from Australia’s Therapeutic Goods Administration (TGA) and a GMP extension from the Brazilian Health Regulatory Agency, ANVISA.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
In this episode, Ill discuss four potential reasons for a false heparin anti-Xa level. Subscribe on iTunes , Android , or Stitcher Monitoring heparin infusions using anti-Xa levels instead of aPTT is becoming a widespread strategy in hospital laboratories. The main benefits of monitoring heparin by anti-Xa are said to be: Better correlation to actual heparin level Better defined target that wont change with each reagent batch (anti-Xa level of 0.3-0.7 IU/mL) Less interference from hemolysis, war
By Richard A. Lewis, Senior Regulatory Device & Biologics Expert & James E. Valentine We recently published the first part of our review of FDAs draft guidance titled Frequently Asked Questions Developing Potential Cellular and Gene Therapy Products. Questions and Answers Guidance (see previous coverage here ). In this post we focus in on the draft guidance documents chemistry, manufacturing, and controls (CMC)-specific content.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
RYZ-101 is a synthetic peptide commercialized by Bristol-Myers Squibb, with a leading Phase III program in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET).
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Vanzacaftor + Deutivacaftor + Tezacaftor is a small molecule commercialized by Vertex Pharmaceuticals, with a leading Pre-Registration program in Cystic Fibrosis.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
105 
Let's personalize your content